# Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers

> **NCT00971295** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 20 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Metformin
- **DRUG:** Eslicarbazepine acetate

## Key facts

- **NCT ID:** NCT00971295
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2007-12
- **Final completion:** 2008-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971295, "Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00971295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*